Our CEO, Rajinder Suri, joined DCVMN members at the 2025 Vaccine Industry Consultation hosted by UNICEF Supply at the Global Supply Hub in Copenhagen. Over three days, manufacturers and global immunization partners discussed market updates across Penta/hexavalent, pneumococcal, rotavirus, HPV, measles-containing, yellow fever, meningitis, polio and emerging vaccines, alongside WHO pre-qualification updates and sessions on local manufacturing, sustainability and logistics.
UNICEF’s market signals and procurement priorities directly shape how manufacturers plan production, investment and supply chains. As the principal, most affordable suppliers of many childhood vaccines, manufacturers from developing countries need predictable demand, feasible timelines for tech transfer, realistic packaging and cold-chain requirements, and financing models that enable sustained capacity rather than intermittent surge production. Bringing these operational realities into the conversation helps turn procurement intents into reliable supply on the ground.
DCVMN used the space to listen, to push for clearer, longer-term signals from buyers, and to flag practical barriers that risk disrupting supply for children. The outcome we want is simple: better-aligned planning between purchasers and producers so that vaccines promised on paper reliably reach immunization programs in the field.
